GFM Network News


ADM beats profit estimates but revenue disappoints

Reuters — Global grains trader Archer Daniels Midland beat Wall Street estimates for quarterly profits on Thursday, helped by strength in its grain milling and nutrition businesses. Still, revenue missed analysts’ expectations and net earnings attributable to the company were 44 per cent lower than a year earlier. Shares were down nearly three per cent […] Read more



Syngenta says IPO ‘on track’

Ag chem firm books higher first-half profit

Zurich | Reuters — Agricultural chemical maker Syngenta posted higher first-half profit and sales on Thursday, helped by maintaining supplies to farmers and controlling costs during the coronavirus outbreak, and said it was on track to complete its public listing by mid-2022. The Swiss company, bought by state-owned ChemChina for $43 billion in 2017, posted […] Read more




CN strike to weigh on railway’s 2019 profit

Reuters — Canadian National Railway on Tuesday cut its adjusted profit growth target for 2019, citing shipment delays from the country’s largest rail strike in a decade that ended last week. Shares in CN, which counts billionaire Bill Gates’ investment firm as its biggest shareholder, fell almost two per cent in morning trading in both […] Read more



Pork supply issues hit Maple Leaf’s Q1 ledger

Reuters — Meat packer Maple Leaf Foods posted a smaller-than-expected quarterly profit as lower prices and a temporary interruption in supplies hurt sales of its pork products, sending its shares to their lowest in nearly two years. The company, one of Canada’s biggest pork processors, said that processed fresh pork sales were affected by a […] Read more



Monsanto surprises with adjusted profit as expenses drop

Reuters — U.S. seeds and agrochemicals company Monsanto, which agreed last month to be bought by Germany’s Bayer for US$66 billion, reported a surprise adjusted profit, helped by a drop in expenses and higher corn seed volumes. Monsanto agreed in September to a sweetened $128-per-share offer from Bayer that, if approved by regulators, would create […] Read more